NAGE NIAGEN BIOSCIENCE INC revenue, earnings and financials

For the quarter ended June 30, 2026, NIAGEN BIOSCIENCE INC reported revenue of $29.8M (down 4.3% from a year earlier), net income of $963K and diluted EPS of $0.01; over the last four quarters revenue was $129M and net income $16.0M; for the fiscal year ended December 2025 revenue was $129M, up 29.9% on the year before.

NAGE annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $129M, gross profit $83.2M, operating income $16.3M, net income $17.4M (margin 13.4%), EPS $0.20
• Fiscal year ended Dec 2024: revenue $99.6M, gross profit $61.6M, operating income $7.73M, net income $8.55M (margin 8.6%), EPS $0.11
• Fiscal year ended Dec 2023: revenue $83.6M, gross profit $50.8M, operating income −$5.60M, net income −$4.94M (margin -5.9%), EPS −$0.07
• Fiscal year ended Dec 2022: revenue $72.1M, gross profit $42.8M, operating income −$18.6M, net income −$16.5M (margin -23.0%), EPS −$0.24
• Fiscal year ended Dec 2021: revenue $67.4M, gross profit $41.5M, operating income −$27.1M, net income −$27.1M (margin -40.2%), EPS −$0.40

NAGE quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $29.8M (down 4.3% year over year), net income $963K, EPS $0.01
• Quarter ended Mar 31, 2026: revenue $31.5M (up 3.3% year over year), net income $6.32M, EPS $0.07
• Quarter ended Dec 31, 2025 (from the annual report): revenue $33.8M (up 16.2% year over year), net income $4.13M, EPS $0.05
• Quarter ended Sep 30, 2025: revenue $34.0M (up 32.9% year over year), net income $4.58M, EPS $0.05
• Quarter ended Jun 30, 2025: revenue $31.1M (up 36.8% year over year), net income $3.61M, EPS $0.04
• Quarter ended Mar 31, 2025: revenue $30.5M (up 37.6% year over year), net income $5.06M, EPS $0.06
• Quarter ended Dec 31, 2024 (from the annual report): revenue $29.1M (up 37.4% year over year), net income $7.18M, EPS $0.10
• Quarter ended Sep 30, 2024: revenue $25.6M (up 31.2% year over year), net income $1.88M, EPS $0.02
• Quarter ended Jun 30, 2024: revenue $22.7M (up 11.9% year over year), net income −$15.0K, EPS $0.00
• Quarter ended Mar 31, 2024: revenue $22.2M (down 1.8% year over year), net income −$492K, EPS −$0.01
• Quarter ended Dec 31, 2023 (from the annual report): revenue $21.2M (up 1.0% year over year), net income $114K, EPS $0.00
• Quarter ended Sep 30, 2023: revenue $19.5M (up 14.3% year over year), net income −$959K, EPS −$0.01
• Quarter ended Jun 30, 2023: revenue $20.3M (up 21.5% year over year), net income −$2.19M, EPS −$0.03
• Quarter ended Mar 31, 2023: revenue $22.6M (up 30.7% year over year), net income −$1.90M, EPS −$0.03
• Quarter ended Dec 31, 2022 (from the annual report): revenue $21.0M (up 18.2% year over year), net income −$1.42M, EPS −$0.03
• Quarter ended Sep 30, 2022: revenue $17.1M (down 1.4% year over year), net income −$985K, EPS −$0.01
• Quarter ended Jun 30, 2022: revenue $16.7M (down 5.5% year over year), net income −$6.40M, EPS −$0.09
• Quarter ended Mar 31, 2022: revenue $17.3M (up 17.5% year over year), net income −$7.74M, EPS −$0.11
• Quarter ended Dec 31, 2021 (from the annual report): revenue $17.8M, net income −$5.33M, EPS −$0.07
• Quarter ended Sep 30, 2021: revenue $17.3M, net income −$8.86M, EPS −$0.13

NAGE cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $13.5M, share buybacks $251K
• Fiscal year ended Dec 2024: operating cash flow $12.1M, share buybacks $0
• Fiscal year ended Dec 2023: operating cash flow $7.12M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$15.1M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$24.2M, share buybacks n/a

NAGE balance sheet

• Jun 30, 2026: cash n/a, total assets $107M, total liabilities $24.1M, shareholders' equity $82.5M
• Mar 31, 2026: cash n/a, total assets $114M, total liabilities $32.0M, shareholders' equity $82.3M
• Dec 31, 2025: cash n/a, total assets $106M, total liabilities $29.9M, shareholders' equity $76.5M
• Sep 30, 2025: cash $64.1M, total assets $98.1M, total liabilities $27.5M, shareholders' equity $70.7M
• Jun 30, 2025: cash $60.3M, total assets $91.5M, total liabilities $27.3M, shareholders' equity $64.2M
• Mar 31, 2025: cash $55.5M, total assets $81.3M, total liabilities $26.0M, shareholders' equity $55.3M
• Dec 31, 2024: cash $44.5M, total assets $68.3M, total liabilities $22.2M, shareholders' equity $46.1M
• Sep 30, 2024: cash $32.2M, total assets $56.5M, total liabilities $22.2M, shareholders' equity $34.4M

What is NAGE's revenue?

NIAGEN BIOSCIENCE INC reported $129M of revenue over its last four quarters, through June 30, 2026.

Is NAGE profitable?

Yes. NIAGEN BIOSCIENCE INC earned $16.0M over the last four quarters.

What is NAGE's EPS?

Diluted earnings per share over the last four quarters were $0.18; $0.01 in the latest quarter.

NAGE ownership and insider trades · All stocks